PERRIGO market cap PRGO
Share price times shares outstanding: what the whole company sells for, since 2013.
- Today, Oct 23, 2026
- $2.2B
- Highest close in our data
- $29B
- May 2015
PERRIGO is worth $2.2B at the close on Oct 23, 2026, at $15.96 a share.
That is down 25% over the last year and down 63% over five years.
Its highest close in our data was $29B in May 2015.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $2.2B | $1.3B | $2.3B | +16% |
| 2025 | $1.9B | $1.7B | $4B | −46% |
| 2024 | $3.5B | $3.3B | $4.6B | −20% |
| 2023 | $4.4B | $3.7B | $5.3B | −5% |
| 2022 | $4.6B | $4.2B | $5.8B | −12% |
| 2021 | $5.2B | $4.8B | $6.5B | −15% |
| 2020 | $6.1B | $5.7B | $8.2B | −14% |
| 2019 | $7.1B | $5.7B | $7.6B | +30% |
| 2018 | $5.4B | $5B | $13.4B | −56% |
| 2017 | $12.3B | $9.5B | $12.5B | +3% |
| 2016 | $11.9B | $11.8B | $21.8B | −44% |
| 2015 | $21.2B | $20.3B | $29B | −5% |
| 2014 | $22.2B | $3.5B | $22.5B | +534% |
| 2013 | $3.5B | $3.4B | $3.6B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest PERRIGO's size, closest first, today.
| Company | Market cap |
|---|---|
| PRGOPERRIGO | $2.2B |
| PBHPrestige Consumer Healthcare | $2.3B |
| HRMYHarmony Biosciences | $2.1B |
| NRIXNurix Therapeutics | $2.8B |
| ANIPANI Pharmaceuticals | $1.7B |
| PAHCPhibro Animal Health | $1.6B |
| ANABAnaptysbio | $1.5B |
| PCRXPacira BioSciences | $1.5B |
| OGNOrganon | $3.6B |
| LQDALiquidia | $3.8B |
| ARQTArcutis Biotherapeutics | $3.9B |
| Peer median | $2.2B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on PERRIGO
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.